SURVEY ON HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTION IN WOMEN WITH CERVICAL SQUAMOUS INTRAEPITHELIAL NEOPLASIA

Việt Nguyễn Hoàng, Đồng Nguyễn Kim, Long Lưu Đức, Lượng Vũ Huy

Main Article Content

Abstract

Objectives: This study aims to assess the prevalence of high-risk Human papillomavirus (hrHPV) infection and the association of HPV 16 and 18 with high-grade squamous intraepithelial lesions (HSILs). Methods: The cross-sectional study included 470 patients who visited Hanoi Medical University Hospital from March 2023 to October 2024. All patients underwent hrHPV testing and cervical biopsies. The statistical analysis was performed using SPSS version 26.0 for Windows. Results and conclusion: The prevalence of hrHPV infection among women with CIN was 94.0%. Among these cases, 42.6% were infected with either HPV 16 or 18. HPV 16 and 18 were detected in CIN 1, CIN 2, CIN3 lesions with rates of 24.9%, 37.3%, 54.5% and 15.7%, 14.9%, 15.2%, respectively. HPV type 16 is the most common type (30.4%), the presence of HPV type 16 increases the risk of CIN 3 by 3.2 times compared to CIN 1 (OR = 3,200, CI: 1,861 – 5,503, p < 0.01).

Article Details

References

1. World Health Organization (‎2022)‎. Cancer today.
2. Ojha PS, Maste MM, Tubachi S, et al (2022). Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies. Virusdisease. 2022 Jun;33(2):132-154.
3. Nguyễn Văn Hưng (2022). Giải phẫu bệnh học. NXB Y học. Tr510.
4. Xi LF, Koutsky LA, Castle PE, et al (2009). Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3490-6.
5. Vũ Thị Nhung, Nguyễn Minh Hiền (2024). Giá trị của xét nghiệm HPV đầu tay trong tầm soát ung thư cổ tử cung. Tạp chí Y học Việt Nam. 541, tr 30 -34.
6. Zhang J, Cheng K, Wang Z (2020). Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis. Arch Gynecol Obstet. 2020 Dec;302(6):1329-1337.
7. Ghaem-Maghami S, Sagi S, Majeed G, et al (2007). Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncol. 2007;8:985–93.
8. Nagai Y, Maehama T, Asato T, et al (2000). Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol 2000;79:294–9.
9. Ramakrishnan S, Partricia S, Mathan G (2015). Overview of high-risk HPV's 16 and 18 infected cervical cancer: pathogenesis to prevention. Biomed Pharmacother. 2015;70:103-110.
10. National Cancer Institute (2020). ACS’s Updated Cervical Cancer Screening Guidelines Explained.